Tokyo: Daiichi Sankyo has announced that it has decided to close its Japanese research and development (R&D) subsidiary, Daiichi Sankyo RD Novare Co., Ltd. (headquartered in Edogawa-ku, Tokyo;.
/PRNewswire/ The Global Health Innovative Technology (GHIT) Fund announced today an investment totaling approximately 260 million yen (US$1.9 million1) for.